FAP and neoplasm: Various strategies targeting FAP, including small molecule inhibitors, monoclonal antibodies (mAbs), antibody–drug conjugates (ADCs), and chimeric antigen receptor T (CAR-T) cells, have demonstrated therapeutic effects in murine tumor models [12,13,14].